Heart of the Family: A Cardiovascular Disease and Type 2 Diabetes Risk Reduction Intervention in High-Risk Rural Families
2 other identifiers
interventional
504
1 country
1
Brief Summary
Rural populations in the U.S. are disproportionately burdened by cardiovascular disease and type 2 diabetes. Lifestyle modification interventions are needed that support long-term engagement in risk-reducing health behaviors. This trial will study the effects of a family-focused, lifestyle intervention that is culturally tailored for use with rural Hispanic and non-Hispanic adults. If successful, this community-based intervention has significant potential for broad dissemination to reduce cardiovascular disease and type 2 diabetes health disparities in rural U.S. communities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Sep 2021
Longer than P75 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 13, 2021
CompletedFirst Posted
Study publicly available on registry
May 18, 2021
CompletedStudy Start
First participant enrolled
September 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2026
CompletedMarch 9, 2026
March 1, 2026
4.3 years
May 13, 2021
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change in body mass index (BMI)
BMI based on measurements of weight and height and calculated as kg/m2.
1 year (baseline, 3 months and 12 months)
Change in blood pressure
Blood pressure assessed using calibrated sphygmomanometry.
1 year (baseline, 3 months and 12 months)
Change in lipid profile
Lipid profile includes LDL-cholesterol, HDL-cholesterol and triglycerides measured using point-of-care testing obtained by fingerstick.
1 year (at baseline, 3 months and 12 months)
Change in hemoglobin A1c (HbA1c)
HbA1c will be measured using point-of-care testing obtained by fingerstick.
1 year (at baseline, 3 months and 12 months)
Change in physical activity level
Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ) to assess the number of days in the last 7 days that the participant engaged in vigorous or moderate physical activity and confirmed by comparing responses to activity levels as determine through actigraphy.
1 year (at baseline, 3 months and 12 months)
Change in dietary intake patterns
Dietary intake patterns will be assessed using the Vioscreen food frequency questionnaire.
1 year (at baseline, 3 months and 12 months)
Change in tobacco use
Tobacco use will be confirmed by collection of a saliva sample to determine cotinine levels.
1 year (at baseline, 3 months and 12 months)
Study Arms (2)
Active Control Arm
ACTIVE COMPARATORAn index participant with 2 or more risk factors for cardiovascular disease or type 2 diabetes who is randomized to this arm will attend 8 weekly educational sessions focused on self-management of risk factors and engagement in healthy behaviors for risk reduction. The index participant will attend the sessions as an individual and will receive standard individual-focused lifestyle modification education.
Family Dyad Arm
EXPERIMENTALAn index participant with 2 or more risk factors for cardiovascular disease or type 2 diabetes and a co-participating family member will together attend 8 weekly educational sessions focused on self-management of risk factors and engagement in healthy behaviors for risk reduction. The dyadic intervention sessions also incorporate family-focused throughout each session to encourage dyadic support.
Interventions
The participant and a co-participating family member will attend 8 sessions that provide type 2 diabetes (T2D) and cardiovascular (CVD) risk reduction and lifestyle modification education focused on CVD and T2D risk factor reduction through promotion of participant self-management. Education will concentrate on healthy eating, physical activity, stress reduction, and other lifestyle risk reduction recommendations.
The participant will attend 8 sessions that provide type 2 diabetes (T2D) and cardiovascular (CVD) risk reduction and lifestyle modification education focused on CVD and T2D risk factor reduction through promotion of participant self-management. Education will concentrate on healthy eating, physical activity, stress reduction, and other lifestyle risk reduction recommendations.
Eligibility Criteria
You may qualify if:
- Primary participants are rural-dwelling Hispanic and non-Hispanic adults who are at-risk for type 2 diabetes or cardiovascular disease and have a family member who is willing to participate if the primary participant is randomly selected to participate with a family member.
- Is Hispanic or non-Hispanic adult
- Is 18 years of age and older
- Is a primary Spanish or English speaker
- Has internet access
- Has two or more risk factors for type 2 diabetes or cardiovascular disease including:
- clinical diagnosis of hypertension;
- clinical diagnosis of hyperlipidemia;
- clinical diagnosis of prediabetes;
- overweight or obese (body mass index ≥ 25 kg/m2);
- is a current cigarette smoker;
- male 45 years of age or older or female 55 years of age or older;
- family history in first degree relative of type 2 diabetes or cardiovascular disease; or
- is a female with a history of gestational diabetes mellitus or polycystic ovary syndrome.
- Lives in rural Kentucky
- +6 more criteria
You may not qualify if:
- Primary participant and family member participant will be excluded if they:
- Have cognitive impairment that preclude them from understanding the consent process, answering questionnaires, or participating in the intervention;
- Have a major psychiatric (e.g., schizophrenia) condition;
- Are pregnant or nursing or plan on becoming pregnant within the next year since dietary needs will be different.
- Have known coronary artery or cerebrovascular disease;
- Have a diagnosis of type 1 or type 2 diabetes;
- Have medical contraindications to participate in a lifestyle intervention that includes unsupervised physical activity and weight loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gia Muddlead
- National Institute of Nursing Research (NINR)collaborator
Study Sites (1)
2201 Regency Rd.
Lexington, Kentucky, 40503, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gia Mudd, RN, PhD
University of Kentucky
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants, intervention providers and assessors are blinded to which arm is the active intervention and which is the active comparator and are blinded to hypotheses regarding group differences.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 13, 2021
First Posted
May 18, 2021
Study Start
September 11, 2021
Primary Completion
January 9, 2026
Study Completion
January 9, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share